Navigation Links
National Eye Institute Launches Ancillary Study to AREDS2 With ForeseeHome(TM) AMD Monitor
Date:6/15/2010

ST. LOUIS, June 15 /PRNewswire/ -- The National Eye Institute, of the U.S. National Institutes of Health, announced the launch of an ancillary study to the ongoing Age-Related Eye Disease Study 2 (AREDS2).  AREDS2 is a nationwide study of 4,000 individuals at moderate to high risk for developing age-related macular degeneration (AMD) to determine whether oral supplementation of lutein/zeaxanthin and omega-3 fatty acids can further slow the progression of vision loss from AMD, the leading cause of vision loss in the United States for people over age 60.

The objective of this ancillary study is to determine if home monitoring using the ForeseeHome™ AMD Monitor would lead to earlier detection of wet AMD when compared with standard care, and result in better visual acuity following therapy at one year.

The ForeseeHome™ AMD Monitor is the first ophthalmic device designed to provide ongoing monitoring of patients with AMD between visits to their eye care professional.  Patients complete a brief exam on their ForeseeHome™ AMD Monitor in the comfort of their own home, and data are transmitted to the Notal Vision Data Monitoring Center.  The award winning ergonomic design of the ForeseeHome™ AMD Monitor is comfortable and easy to use for patients at risk of vision loss from AMD.

Notal Vision was founded by a team of medical professionals determined to develop better methods of AMD monitoring and reduce vision loss associated with AMD. For more information, please visit www.notalvision.com.

The National Eye Institute (NEI) is part of the National Institutes of Health (NIH) and is the Federal government's lead agency for vision research that leads to sight-saving treatments and plays a key role in reducing visual impairment and blindness. For more information, visit the NEI Website at http://www.nei.nih.gov/.

The National Institutes of Health (NIH) - The Nation's Medical Research Agency - includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical, and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov/.


'/>"/>
SOURCE Notal Vision
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results
2. Veteran International Health Care Executive Appointed CEO of BeneChill(R)
3. Abstract Submissions and Registration Now Open for 2nd International Symposium on MR-Guided Focused Ultrasound
4. AstraZeneca to Support Drug-Induced Liver Injury Network at the National Institutes of Health
5. CSL Behring Announces Completion of National Marketing Authorizations of Berinert® After MRP in 23 European Countries
6. HealthWarehouse.com Receives VIPPS Accreditation From The National Association of Boards of Pharmacy
7. National Anesthesia Services, Inc. Celebrates 21 Years of Dynamic Growth and Achievement
8. Systech International and Videojet Brazil Partner to Meet Brazils Emerging Pharmaceutical Regulatory Requirements
9. Drug Production in Afghanistan: A Challenge for the International Community
10. China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010
11. OXIS International, Inc. Announces Its Attendance at the Rodman & Renshaw Annual Global Investment Conference in London, May 16-18, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... 26, 2016 One of Australia,s ... formation of a new biotechnology company, Noxopharm Limited [ABN 50 608 ... IPO and to list on the ASX. Noxopharm is ... to enter a Phase 1 clinical study later this year. ... one of the biggest problems facing cancer patients - the ability ...
(Date:6/26/2016)... DUBLIN , June 27, 2016 Jazz ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... proposed acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... 11:59 p.m. (Eastern Daylight Time). As previously ... entered into a definitive merger agreement under which Jazz ...
(Date:6/26/2016)... 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) ... measures required to build a strong and stable market ... listed on the OTC Markets-pink current trading platform. ... "We are seeing an anomaly in market trading activities ... by the Company, but shareholders and market players as ...
Breaking Medicine Technology:
(Date:6/27/2016)... CA (PRWEB) , ... June 27, 2016 , ... ... College District , the only authorized OSHA Training Institute Education Center headquartered in ... by protecting their workers from extreme heat at their worksites. Employers with ...
(Date:6/27/2016)... ... 2016 , ... "FCPX editors can now reveal their media with growing colorful ... Christina Austin - CEO of Pixel Film Studios. , ProSlice Color brings the ... can now reveal the media of their split screens with growing colorful panels. , ...
(Date:6/27/2016)... , ... June 27, 2016 , ... ... mental health professionals, announced today its affiliation with Tennessee Counseling Association. ... to the network of the Tennessee Counseling Association, adding exclusive benefits and promotional ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... payment industry today announced its strategic partnership with Connance, a healthcare industry ... The two companies’ proven, proprietary technology combine to provide health systems, hospitals ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... cutting edge technology to revolutionize the emergency ambulance transport experience for the millions ... aware of how Uber has disrupted the taxi industry through the use of ...
Breaking Medicine News(10 mins):